Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

cyclopia sequence 8Lung Neoplasms 3Pain 2Neoplasms, Plasma Cell 2Multiple Myeloma 2Carcinoma, Non-Small-Cell Lung 2Breast Neoplasms 2Sleepiness 1Peripheral Nervous System Diseases 1Parasomnias 1Pancreatic Neoplasms 1Oropharyngeal Neoplasms 1Neoplasm Metastasis 1Hypesthesia 1Head and Neck Neoplasms 1Glioma 1Glioblastoma 1Fatigue 1Exanthema 1Esophageal Neoplasms 1Depression 1Colorectal Neoplasms 1Anxiety Disorders 1Anorexia 1Acute Pain 1

Interventions

Fluorouracil 255Leucovorin 224Oxaliplatin 218Irinotecan 206Bevacizumab 200Capecitabine 144Cetuximab 136Panitumumab 68Folfox protocol 63regorafenib 50Colonoscopy 44pembrolizumab 42IFL protocol 39Radiotherapy 32Nivolumab 31Drug Therapy 27trifluridine tipiracil drug combination 26Gemcitabine 24Blood Specimen Collection 23Chemotherapy, Adjuvant 20Surveys and Questionnaires 19Celecoxib 19Surgical Procedures, Operative 16durvalumab 15Neoadjuvant Therapy 15Cyclophosphamide 14Cisplatin 14aflibercept 13Standard of Care 13Pemetrexed 13

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Colorectal Neoplasms × Minocycline × Clear all
NCT01906008 2020-03-17

Phase II Study of Minocycline for Reducing Symptom Burden in Colorectal Patients

M.D. Anderson Cancer Center

Phase 2 Completed
122 enrolled 9 charts
Gastrointestinal

cyclopia sequence, Hypesthesia, Pain, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡